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Previously, we found that the teleost ﬁsh, rainbow trout, possesses two growth hormone
receptor (GHR) subtypes that display distinct ligand-binding and agonist-induced regulation
features. In this study, we used Chinese hamster ovary-K1 cells stably transfected individ-
ually with the two trout GHR subtypes, GHR1 and GHR2, to elucidate receptor–effector
pathway linkages. Growth hormone (GH) stimulated rapid (5–10min) phosphorylation of
ERK, Akt, JAk2, and STAT5 in both GHR1- and GHR2-expressing cells; however; STAT5
was activated to a greater extent through GHR1 than through GHR2, whereas ERK and
Akt were activated to a greater through GHR2 than through GHR1. Although blockade of
the ERK pathway had no effect on the activation of Akt, inhibition of PI3K–Akt partially pre-
vented activation of ERK, suggesting cross-talk between the ERK and PI3K–Akt pathways.
JAK2 inhibition completely blocked activation of ERK, Akt, and STAT5, suggesting that all
of these pathways link to GHR1 and GHR2 via JAK2. These ﬁndings establish important
receptor–effector pathway linkages and suggest that the GHR subtypes of teleost ﬁsh may
be functionally distinct.
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INTRODUCTION
Growth hormone (GH) regulates a host of physiological processes
including feeding, growth, metabolism, reproduction, immune
function, behavior, and, in teleost (bony) ﬁsh, osmoregulation
(Forsyth andWallis, 2002; Bjornsson et al., 2004; Norrelund, 2005;
Wood et al., 2005; Moller and Jorgensen, 2009). The actions of
GH are initiated by binding to GH receptors (GHRs), which are
members of the class I cytokine receptor family and which con-
sist of a single transmembrane protein containing an extracellular
ligand-binding domain and an intracellular signal transduction
domain (Argetsinger and Carter-Su, 1996). In keeping with the
pleiotropic actions of GH, GHRs are widely distributed among
tissues of mammals and ﬁsh (Kopchick and Andry, 2000; Butler
and LeRoith, 2001; Wood et al., 2005). Fish possess multiple GHR
subtypes that derive from separate genes that arose through vari-
ous genome duplication events during the evolution of this taxon
(Reinecke et al., 2005; Fukamachi and Meyer, 2007; Li et al., 2007;
Gao et al., 2011). There has emerged two distinct clades of GHRs,
sometimes referred to as GHR type 1 and GHR type 2 (cf. Saera-
Vila et al., 2005); however, Fukamachi and Meyer (2007) suggested
that type 1 GHRs should be called somatolactin receptors (SLR),
but such a designation may not be applicable for all teleosts (Ozaki
et al., 2006; Chen et al., 2011). Regardless, the GHR subtypes of
ﬁsh are differentially expressed in a tissue-speciﬁc manner, and
the individual GHR subtypes have distinct yet overlapping ligand-
binding and agonist-induced regulation features (Fukada et al.,
2004, 2005; Very et al., 2005; Ozaki et al., 2006; Ma et al., 2007;
Norbeck et al., 2007; Reindl et al., 2009; Di Prinzio et al., 2010;
Chen et al., 2011). Several studies in ﬁsh have shown that the
pattern of GHR expression can be regulated by numerous nutri-
tional, hormonal, and external environmental factors (Norbeck
et al., 2007; Reinecke, 2010; Reindl and Sheridan, 2011).
Post-receptor signaling events for GH in mammalian systems
are well characterized. GH binding to dimerized GHRs is fol-
lowed by recruitment of JAK2 to the receptor complex and the
rapid phosphorylation of GHR and JAK2; signal is propagated
by activation of several other proteins and pathways, including
IRS-1 and STAT5 as well as the ERK and PI3K–Akt pathways
(Piwien-Pilipuk et al., 2002). Speciﬁc linkages between partic-
ular effector pathways and biological responses also are known
in mammals. For example, the insulin-like metabolic effects of
GH are mediated by IRS-1, whereas the proliferative effects of
GH are mediated by Akt (Frago and Chowen, 2005). Far less has
been reported about the mechanism(s) of GH action in ﬁsh, and
virtually nothing is known about GHR subtype-effector pathway
linkages. Recently, we reported that GH activates the ERK and
PI3K–Akt pathways in the liver of rainbow trout and that these
signal cascades play a role in GH-stimulated IGF-1 expression
(Reindl et al., 2011).
In this study, we took advantage of the unique evolution-
ary history of teleost ﬁsh to examine the function of duplicated
GHRs by establishing receptor–effector pathway linkages for the
GHR subtypes. To this end, Chinese hamster ovary cells (CHO)
cells were individually transfected with plasmids that contained
cDNAs encoding rainbow trout GHR1 and GHR2. The examina-
tion of expressed GHRs allowed us to test the hypothesis that the
GHR subtypes of teleost ﬁsh differentially activate cellular effector
pathways.
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MATERIALS AND METHODS
MATERIALS
All chemicals and reagents used were purchased from Sigma
(St. Louis, MO, USA) unless stated otherwise. Antibodies
for the phospho-speciﬁc and total (recognizing both phos-
phorylated and non-phosphorylated protein) forms of Akt,
ERK1/2, JAK2, and STAT5, horseradish peroxidase (HRP)-
linked anti-rabbit IgG antibody, biotinylated molecular weight
marker, anti-biotin-HRP antibody, mitogen-activated protein
kinase kinase 1/2 (MEK1/2) inhibitor U0126 (MEK1 and 2
are directly responsible for the activation of ERK), PI3K
inhibitor LY294002 [PI3K produces phosphatidylinositol phos-
phates that are critical for activation of Akt by phosphoinositide-
dependent kinase 1 (PDK1)], and cell lysis buffer were
all obtained from Cell Signaling Technology (Beverly, MA,
USA). The JAK2 inhibitor, 1,2,3,4,5,6-hexabromocyclohexane
(Hex), as well as the STAT5 inhibitor, N ′-((4-oxo-4H-
chromen-3-yl)methylene)nicotinohydrazide (Nico), and the Akt
inhibitor, 1L6-hydroxymethyl-chiro-inositol-2-(R)-2-O-methyl-
3-O-octadecyl-sn-glycerocarbonate (Carb), were obtained from
EMDChemicals (Gibbstown,NJ,USA).Molecularweightmarkers
were purchased from Bio-Rad Laboratories (Hercules, CA, USA).
CELL LINE, PLASMID CONSTRUCTION, AND CELL TRANSFECTION
Growth hormone receptor subtype-effector pathway linkages
were studied in CHO cells (CHO-K1 wild type; American Type
Culture Collection, Rockville, MD, USA) individually trans-
fected with plasmids containing rainbow trout GHR1 (acces-
sion no. AY861675) and GHR2 (accession no. AY751531). CHO
cells were routinely maintained in 5% CO2 and 95% rela-
tive humidity at 37˚C in Ham’s F-12 nutrient mixture sup-
plemented with 10% fetal calf serum (FCS), 100U/ml peni-
cillin, 100μg/ml streptomycin, and 0.1% (v/v) fungizone (base
medium). For passage, the cells were detached from the cul-
ture ﬂasks by washing with phosphate-buffered saline (PBS)
followed by brief incubation in trypsin (0.5mg/ml)/EDTA
(0.2mg/ml). The cells were split every 3 days. For storage, cells
were resuspended in base medium containing dimethyl sul-
foxide (10% ﬁnal concentration) and frozen in liquid nitro-
gen.
Growth hormone receptor-encoding cDNAs were prepared
from total RNA extracted from the liver of rainbow trout
(Oncorhynchus mykiss) as described previously (Reindl et al.,
2009). Brieﬂy, ﬁrst-strand cDNA as prepared from total RNA with
the Clontech SMART™RACE cDNA ampliﬁcation kit (Clontech
Laboratories, Inc., Mountain View, CA, USA) which was then
used as template for PCR using speciﬁc primers for each trout
GHR-encoding cDNA (Reindl et al., 2009).
PCR products were cloned directly into the pcDNA™3.1(+)
mammalian cell expression vector (InvitrogenCorporation,Carls-
bad, CA, USA), which contains the neomycin phosphotrans-
ferase gene that confers resistance to the neomycin analog,
geneticin (G418). Positive colonies were identiﬁed by agarose gel
electrophoresis of restriction enzyme digests (EcoRI; Promega)
of puriﬁed plasmid preparations (Wizard® Plus SV Minipreps,
Promega Corporation, Madison,WI, USA). To verify the presence
of the trout encodingGHR sequences, plasmidDNA (75 fmol) was
sequenced with the CEQ 2000 sequencer using the Dye Termina-
torCycle SequencingQuick Start Kit (BeckmanCoulter; Fullerton,
CA, USA) according to the manufacturer’s protocol.
Stable transfection of CHO-K1 cells was accomplished as pre-
viously described (Reindl et al., 2009). Brieﬂy, CHO-K1 cells (ca.
4× 105) in 0.4ml of ice-cold electroporation medium (Ham’s
F-12K without FCS or antibiotics) were combined with 10μg
puriﬁed plasmid in a 0.4-cm gene pulse cuvette. The cuvette con-
taining the cells and DNA was placed in a BTX ECM399 (Harvard
Apparatus, Inc., Holliston, MA, USA) pulse chamber, and pulsed
once for 30ms at 250V. The cells were diluted with an appro-
priate volume of base medium, then plated, and allowed to grow
for 48 h before applying selection medium. The selection medium
consisted of base medium with 500μg/ml (ﬁnal concentration)
G418. The culture medium was replaced every 48–72 h, and after
14 days in selection medium, the G418-resistant clones were sub-
cultured for binding analysis. Three sub-clones of CHO cells were
generated: one for each GHR-encoding cDNA (GHR1 and GHR2)
and one that was transfected with vector only as a control.
EXPERIMENTAL CONDITIONS
The activation of signaling pathways was studied in transfected
CHO cells essentially as described previously (Hagemeister et al.,
2010). Cells (1.5× 105 cells) were seeded into each well of a 24-
well culture plate and incubated (37˚C, 5% CO2, 95% humidity)
in base medium without FCS until the cells attached ﬁrmly to the
plate and reached 90% conﬂuency (ca. 24 h). After washing the
cells three times with base medium, they were treated with either
medium alone or with varying concentrations of salmonid GH,
and incubated for the times speciﬁed in the ﬁgures under the same
conditions as attachment. In combination experiments involv-
ing U0126, LY294002, Hex, Nico, or Carb, the speciﬁc inhibitor
was added 2 h prior to hormone treatment. Following incubation,
the cells were again washed three times with base medium, then
lysed with 100μl 1× cell lysis buffer with 1mM phenylmethylsul-
fonyl ﬂuoride (PMSF). Lysates were incubated on ice for 5min,
reﬂuxed 20 times with a micropipette, then centrifuged at 16000 g
for 15min at 4˚C. Protein concentration was determined on the
resulting supernatant using the Bio-Rad (Hercules, CA,USA) dye-
binding method. Each well of a 24-well plate, yielded ca. 2mg of
lysate protein, was considered an individual replicate. Each exper-
iment was repeated three times, using sub-clones from separate
transfections.
ANALYSIS OF [125I]-GROWTH HORMONE BINDING
Analysis of [125I]-GH binding was performed on microsomes iso-
lated from clonal lines of CHO-K1 cells transfected with cDNAs
encoding rainbow trout GHR1 or GHR2. Microsomes were iso-
lated from CHO cells (ca. 12× 106 cells) harvested from 6-well
culture plates as described previously (Reindl et al., 2009). Binding
assays were conducted using the method described by Gray et al.
(1990). Salmonid GH was iodinated with [125I]-sodium iodide
(ICNBiomedicals, Irvine,CA,USA) as describedpreviously (Gong
et al., 2004).
WESTERN BLOTTING
Samples containing ca. 50μg of total protein were separated on a
7.5% SDS-PAGE gel and transferred to a 0.45-μm nitrocellulose
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membrane (Bio-Rad Laboratories, Hercules, CA, USA) for West-
ern analysis as previously described (Reindl et al., 2011). Mem-
branes were visualized with enhanced chemiluminescence accord-
ing to the manufacturer’s instructions (GE Healthcare, Buck-
inghamshire, UK) followed by exposure of X-ray ﬁlm (cat no.
F-BX-57; Phenix Research Products, Hayward, CA, USA); the ﬁlm
was scanned and the bands quantiﬁedwith anAlphaImager (Alpha
Innotech, San Leandro, CA, USA).
STATISTICS
Quantitative data are expressed as means± SEM. Statistical differ-
ences were estimated by ANOVA followed by Duncan’s multiple-
range test. A probability level of 0.05 was used to indicate
signiﬁcance.
RESULTS
Two full-length cDNAs containing the entire coding regions of
GHR1 and GHR2 were obtained by RT-PCR for use in the stable
transfection of CHO-K1 cells. The sizes of the resulting cDNAs
(1910 bp for GHR1 and 1946 bp for GHR2) matched values pre-
dicted from primer locations and were identical to those obtained
previously (Reindl et al., 2009). Nucleotide sequencing veriﬁed
that no random mismatching of base pairs or point mutations
occurred during plasmid construction. The GHR1 cDNA encoded
a 593-amino acid protein and the GHR2 cDNA encoded as 594-
amino acid protein, observations that were identical to those
reported originally for rainbow trout GHRs (Very et al., 2005).
The functional expression of the trout GHRs was assessed by
speciﬁc binding of [125I]-sGH to microsomes isolated from trans-
fected cells. CHO-K1 cells individually transfected with plasmids
containingGHR1 andGHR2 cDNAs displayed signiﬁcantly higher
speciﬁc binding than non-transfected cells (Table 1). However, a
comparable level of expressionwas achieved inGHR1- andGHR2-
transfected cells. Typically, 25,000 cpm of labeled sGH was added
to each reaction containing 50μg of microsomal protein. Under
these conditions, speciﬁc binding ranged from 5.1 to 5.5% of total
radioactivity added and up to 60–80% of total [125I]-sGH bound;
non-speciﬁc binding averaged 27.6± 7.9%.
Phospho-speciﬁc and total antibodies were used to study the
effects of GH on activation of the ERK, PI3K/Akt, and JAK/STAT
pathways via GHR1 and GHR2. GH treatment resulted in rapid
phosphorylation of JAK2 in both GHR1- and GHR2-expressing
cells (Figure 1). Maximum phosphorylation was observed within
5min in both GHR-expressing lines; thereafter, JAK2 activation
Table 1 | Specific binding of [125I]-salmonid growth hormone to
microsomes isolated from Chinese hamster ovary-K1 cells
individually transfected with vector only or with vector containing
cDNA that encodes rainbow trout growth hormone receptor 1 (GHR1)
or growth hormone receptor 2 (GHR2).
Vector only GHR1 GHR2
137±31a 1266±42b 1374±53b
Units of speciﬁc activity are counts per minute; data are expressed as
means±SEM for triplicate determinations from three independent experiments.
Groups with different letter are signiﬁcantly different from each other (P<0.050).
declined, returning to levels observed in control after 10min. GH
also stimulated phosphorylated STAT5 in both GHR-expressing
lines. STAT5 activation was greatest in GHR1-expressing cells
treated with GH for 10–30min, and although the degree of
phosphorylation of STAT5 was less in GHR2-expressing cells
than in GHR1-expressing cells, GH-stimulated signiﬁcant STAT5
activation in GHR2-expressing cells 10min after GH treatment.
Growth hormone exposure also induced ERK 1/2 phosphory-
lation in a time-dependent manner in both of the GHR-expressing
CHO cell lines (Figure 1). For the GHR1-expressing line,maximal
phosphorylation of ERK 1/2 occurred within 10min; thereafter,
pathway activation decreased, reaching control levels after 60min.
A similar time course was observed in GHR2-expressing cells,
but the extent of activation was signiﬁcantly greater than that
observed in GHR1-expressing cells. GH treatment also activated
the PI3K/Akt pathway in a time-dependent manner in both of
the GHR-expressing cell lines (Figure 1). Similar to ERK path-
way activation, maximum activation of Akt in both the GHR1-
and GHR2-expressing cells was observed 10min after treatment;
thereafter, phosphorylation state degraded rather rapidly, but it
remained slightly but signiﬁcantly elevated above control levels up
to 60min after treatment.
The efﬁcacy and potency of GH-stimulated pathway activation
also was investigated (Figure 2). GH-stimulated the phosphory-
lation of JAK2 in a concentration-related manner with signiﬁcant
activation observed at a GH concentration as low as 1 ng/ml;
however, there was no difference in efﬁcacy or potency between
the GHR1- and GHR2-expressing cells (data not shown). ERK
1/2 phosphorylation also was stimulated by GH in each of the
GHR-expressing cell lines in a concentration-dependent man-
ner (Figure 2A). However, not only was the ERK pathway acti-
vated to a greater extent (i.e., more potent) in GHR2-expressing
cells than in GHR1-expressing cells, but the efﬁcacy of GH in
stimulating the ERK pathway was greater in GHR2-expressing
FIGURE 1 | Growth hormone (GH) activates multiple signal pathways
via rainbow trout GH receptors (GHR) transfected in Chinese hamster
ovary (CHO)-K1 cells. CHO-K1 cells were stably transfected with cDNA
encoding rainbow trout GHR1 and GHR2. Cells were incubated with
100 ng/ml salmonid GH for various times; after which, the cells were
collected and lysed. Lysates were separated by SDS-PAGE followed by
Western immunoblotting using phospho-speciﬁc (pERK 1/2, pAkt, pJAK2,
pSTAT5) and total (tERK 1/2; tAkt, tJAK2, tSTAT5) antibodies.
www.frontiersin.org September 2011 | Volume 2 | Article 30 | 3
Kittilson et al. Growth hormone receptor signaling
cells (EC50 = 3.4 ng/ml) than that in GHR1-expressing cells
(EC50 = 85 ng/ml).
Growth hormone also activated Akt in a concentration-
dependent manner (Figure 2B). Similar to the case with ERK acti-
vation, the efﬁcacy of activating the PI3K/Akt pathway was greater
in GHR2-expressing (EC50 = 4.4 ng/ml) cells than in GHR1-
expressing cells (EC50 = 22 ng/ml); however, there was no differ-
ence between the GHR1 cells and the GHR2 cells in the potency
of GH to activate the PI3K/Akt pathway.
Growth hormone also stimulated phosphorylation of STAT5 in
a concentration-related manner. In contrast to the action of GH
on the activation of the ERK and PI3K/Akt pathways, however,
the efﬁcacy of GH for activating STAT5 was greater in GHR1-
expressing cells than in GHR2-expressing cells (Figure 2C). GH-
stimulated signiﬁcant phosphorylation of STAT5 at 1 ng/ml; the
EC50 for GHR1 (4.3 ng/ml) was signiﬁcantly less than the EC50
(78 ng/ml) for GHR2-expressing cells.
The linkage of GHRs to the ERK, PI3K/Akt, and/or JAK/STAT
pathways was conﬁrmed by the use of speciﬁc pathway inhibitors
(Figure 3). GH-induced phosphorylation of ERK 1/2 in both
the GHR1- and GHR2-expressing cells was blocked by the MEK
inhibitor, U0126 (Figure 3A). Inhibition of MEK with U0126 had
no effect on GH-induced activation of Akt or STAT5 in either
of the GHR-expressing cells. GH- induced phosphorylation of
Akt in both GHR-expressing cell lines was completely blocked by
the PI3K inhibitor, LY294002. That this effect on GH-induced
phosphorylation of Akt resulted from direct inhibition of Akt was
conﬁrmed by the action of the speciﬁc Akt inhibitor, Carb. Inter-
estingly, while the MEK inhibitor had no effect on GH-stimulated
Akt activation, the PI3K inhibitor and the direct Akt inhibitor par-
tially blocked GH-stimulated ERK activation in both GHR1- and
GHR2-expressing cells (Figure 3B).Neither thePI3K inhibitor nor
the direct Akt inhibitor affected GH-induced phosphorylation of
STAT5 in either GHR-expressing cell line (Figure 3C). It should
be noted that although a difference was observed between the two
GHR-expressing cells with regard to the response of LY294002 on
GH-induced activation of ERK, this difference was reﬂective of
the differential responsiveness of GH on ERK activation between
GHR1- and GHR2-expressing cells (Figure 3A).
Growth hormone-induced phosphorylation of STAT5 was
blocked by the JAK inhibitor, Hex, in both GHR1- and GHR2-
expressing cells (Figure 3C). Interestingly, the JAK inhibitor also
completely blocked GH-induced activation of ERK and Akt in
both GHR-expressing cells. That at least some of the effects of
STAT blockade on GH-induced activation were direct rather than
mediated through other pathways was conﬁrmed by the effects of
the speciﬁc STAT5 inhibitor,Nico; the STAT inhibitor had no effect
onGH-induced activationof ERKorAkt in eitherGHR-expressing
cell line (Figures 3A,B).
DISCUSSION
Understanding the molecular basis of GH action in teleost ﬁsh is
complicated by the existence of multiple GHR subtypes that dis-
play both distinct and overlapping ligand-binding characteristics
(Fukada et al., 2004, 2005;Very et al., 2005;Ozaki et al., 2006; Fuka-
machi and Meyer, 2007; Li et al., 2007; Ma et al., 2007; Chen et al.,
2011; Gao et al., 2011). In this study, we took advantage of stably
transfected CHO-K1 cells to establish for the ﬁrst time receptor-
effector pathway linkages for teleost GHRs. The transfected CHO-
K1 cells synthesized rainbow trout GHRs mRNAs and correctly
targeted the receptor proteins to the cell surface; binding analysis
conﬁrmed that both of the GHR-expressing cell lines (GHR1 and
GHR2) were functional and bound [125I]-GH—observations that
were consistent with our previous results in which expressed rain-
bow trout GHR1 and GHR2 bound [125I]-GH with high afﬁnity
(Reindl et al., 2009). The present ﬁndings demonstrated linkages
FIGURE 2 | Growth hormone receptors (GHR) subtypes
differentially activate (A) ERK, (B) Akt, and (C) STAT5. CHO-K1
cells were stably transfected with cDNA encoding rainbow trout GHR1
and GHR2. Cells were incubated with various concentrations of salmonid
GH for 10min (control is 0 ng/ml); after which time, the cells were
collected and lysed. Lysates were separated by SDS-PAGE followed
byWestern immunoblotting using phospho-speciﬁc (pERK 1/2, pAkt,
pJAK2, pSTAT5) and total (tERK 1/2; tAkt, tJAK2, tSTAT5) antibodies.
Data are expressed as percentage of control and are presented
as means±SEM (n =8) of blots quantiﬁed with a digital imaging
system; * designates groups that are signiﬁcantly different from each
other (P<0.05).
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FIGURE 3 | Effects of pathway blockade on growth hormone-induced
activation of (A) ERK, (B) Akt, and (C) STAT5. CHO-K1 cells were stably
transfected with cDNA encoding rainbow trout GHR1 and GHR2.
Transfected cells were pretreated with or without speciﬁc inhibitors [10μM
of the MEK inhibitor, U0126; 20μM of the PI3K inhibitor, LY294002 (LY);
25μM of the Akt inhibitor, 1L6-hydroxyymethyl-chiro-inositol-2-(R)-2-O-
methyl-3-O-octadecyl-sn-glycerocarbonate (Carb); 200μM of the STAT5
inhibitor, N ′-((4-oxo-4H-chroen-3-yl)methylene)nicotinohydrazide (Nico); and
50μM of the JAK2 inhibitor, 1,2,3,4,5,6-hexabromocyclohexane (Hex)] for
2 h, then treated with or without 100 ng/ml growth hormone (GH) for 10min
(control is 0 ng/ml GH); after which time, the cells were collected and lysed.
Cell lysates were separated by SDS-PAGE followed byWestern
immunoblotting using phospho-speciﬁc (pERK1/2, pAkt, or pSTAT) and total
(tERK1/2, tAkt, or tSTAT) antibodies. Data are expressed as percentage of
control and are presented as means±SEM (n =8). For a given GHR
subtype, groups with different letters are signiﬁcantly different from each
other (P<0.05); * designates a signiﬁcant difference (P<0.05) between
subtypes within a given treatment.
between ﬁsh GHRs and the JAK–STAT, ERK, and PI3K–Akt path-
ways and provide insight into the molecular mechanisms by which
GH may elicit speciﬁc physiological effects in target cells.
Rainbow trout GHRs activate the ERK signaling pathway. This
conclusion is supported by the observation that GH-stimulated
ERK 1/2 phosphorylation in both of the GHR-expressing cell
lines. Furthermore, blockade of the ERK pathway with the MEK
inhibitor,U0126, prevented GH-induced phosphorylation of ERK
1/2. These ﬁndings are consistent with previous studies in native
FIGURE 4 | Model of differential activation of signaling pathways by
growth hormone receptor (GHR) subtypes. JAK2 activation is essential
for propagation of signaling from both GHR1 and GHR2 to the ERK,
PI3K/Akt, and STAT5 pathways (details of pathway elements are omitted for
simplicity). Cross-talk occurs between the ERK and PI3K/Akt pathways,
possibly through Akt activation of c-Raf in the ERK pathway.
systems of ﬁsh in which GH-induced ERK activation in hepa-
tocytes incubated in vitro (Reindl et al., 2011). The involvement
of ERK in conducting GH intracellular signaling also has been
studied in mammalian systems (Piwien-Pilipuk et al., 2002).
Rainbow trout GHRs also activate the PI3K/Akt pathway. This
conclusion is supported by the observation that in both GHR-
expressing cell lines, GH-induced the phosphorylation of Akt, a
signaling element downstream of PI3K. In addition, the PI3K
inhibitor, LY294002, blocked GH-stimulated Akt phosphoryla-
tion. That GH-stimulated activation of Akt was dependent on
PI3K was conﬁrmed by the observation that the Akt-speciﬁc
inhibitor, Carb, blocked Akt activation to the same extent as the
PI3K inhibitor, LY294002. These ﬁndings are consistent with pre-
vious studies in trout that showed that GH activates Akt in liver
cells in vitro (Reindl et al., 2011). The PI3K–Akt pathway also
is known to mediate the action of GH in mammalian systems
(Argetsinger and Carter-Su, 1996).
There is cross-talk between the ERK and PI3K–Akt pathways.
This notion is supported by the observation that inhibition of both
PI3K (via LY294002) and Akt directly (via Carb) partially blocked
GH-induced phosphorylation of ERK. That the activation of ERK
was partially dependent on Akt and not vice versa was supported
by the observation that ERK pathway blockade by U0126 had no
effect on Akt activation in either GHR-expressing cell line. Cross-
talk between the PI3K/Akt pathway and ERK pathway has been
shown in mammals, with c-Raf serving as a nexus between the
two pathways and establishing and PI3K–c-Raf–MEK–ERK cas-
cade (Zimmermann and Moelling, 1999; Reusch et al., 2001). It
should be noted that the because the Akt and PI3K inhibitors
knocked down some but not all GH-induced activation of ERK,
upstream elements other than PI3K may serve to activate the
c-Raf–MEK–ERK cascade.
Rainbow trout GHRs activate the JAK–STAT signaling pathway
in addition to the ERK and PI3K–Akt pathways. This conclusion
is supported by the observation that GH-stimulated phospho-
rylation of JAK2 and STAT5 in both GHR-expressing cell lines.
Moreover, the JAK2-speciﬁc inhibitor,Hex, and the STAT5 speciﬁc
inhibitor, Nico, prevented GH-stimulated phosphorylation of
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STAT5 in both GHR-expressing cell lines. These ﬁndings are con-
sistent with previous studies in native systems of ﬁsh in which
GH-induced activation of JAK2 and STAT5 in hepatocytes (Reindl
et al., 2011) as well as with studies in mammalian systems (Carter-
Su et al., 2000; Waters et al., 2006). That JAK2 is most proximal
to GHR and is critical for signal propagation through either the
ERK or PI3K/Akt pathways was supported by several observa-
tions. Although the ERK pathway inhibitor, U0126, the PI3K
inhibitor, LY294002, and the Akt inhibitor, Carb, had no effect
on the phosphorylation of STAT5, the JAK2 inhibitor, Hex, com-
pletely inhibited ERK, and Akt activation in addition to inhibition
of STAT5. These ﬁndings are consistent with the observations that
JAK2 activation is the initial step in GH signal transduction in
mammalian systems and that activationof theERKandPI3Kpath-
ways are downstream of JAK (Piwien-Pilipuk et al., 2002; Waters
et al., 2006).
The current ﬁndings indicate that there are signiﬁcant differ-
ences in the efﬁcacy of the two rainbow trout GHR subtypes to
activate ERK, PI3K–Akt, and STAT pathways. The ERK and the
PI3K–Akt pathways were preferentially activated through rain-
bow trout GHR2, whereas STAT5 was preferentially activated
through rainbow trout GHR1. Previous studies have shown that
the ERK and PI3K–Akt pathways differentially link to subtypes of
the somatostatin receptors of ﬁsh and mammals (Charland et al.,
2001; Hagemeister et al., 2010). The molecular basis(es) for these
preferentially linkages is(are) not known, but it(they) probably
result(s) from structural differences among the receptor subtypes.
In the case of the rainbow trout GHRs, despite their overall sim-
ilarity (85.5% amino acid identity between GHR1 and GHR2),
there are several notable differences in the intracellular domain,
particularly the Box 1 region (Very et al., 2005) – a region that
has been found to play an important role in coupling to cellular
effector pathways in mammals (Carter-Su et al., 2000; Kopchick
and Andry, 2000). A model of the mechanisms activated by GH
through rainbow troutGHRs is depicted inFigure 4. In thismodel,
the binding of GH to GHR initiates a progression of events, from
activation of JAK2 to differential propagation via ERK, PI3K–Akt,
and STAT5. It should be noted that the cross-talk between the Akt
and ERK pathways must be governed in some manner in order to
explain the observed differential activation of Akt by GHR and of
ERK by GHR2.
The observed differential linkages to cellular effector path-
ways provide some insight into the functional signiﬁcance of
GHR subtypes in teleost ﬁsh. By GH binding to one or the other
forms of GHR in native cells, a speciﬁc complement of signal-
ing pathways would be activated. While there are no direct data
in ﬁsh regarding linkages between speciﬁc pathways and biolog-
ical responses, there are studies in mammals showing that IRS-1
mediates the insulin-like metabolic effects of GH and that Akt
mediates the proliferative effects of GH (Frago and Chowen,
2005). The situation is complicated in ﬁsh in that native cells
often express a mixture of GHR subtypes (Reinecke et al., 2005;
Saera-Vila et al., 2005; Very et al., 2005; Ozaki et al., 2006; Fuka-
machi and Meyer, 2007; Li et al., 2007; Ma et al., 2007; Gao
et al., 2011). However, there is some evidence in ﬁsh that the
GHR subtypes link to different actions. Using a reporter system
in CHO cells, Jiao et al. (2006) showed that GH binding to sea
bream (sb) GHR1 and sbGHR2 activated transcription of Spi
2.1 and β-casein, whereas sbGHR1 but not sbGHR2 mediated
GH activation of the c-fos promoter. In addition, the pattern of
expression of GHR subtypes in native cells differs with nutrition,
stage of sexual maturation, and the nature of osmotic environ-
ment in which the ﬁsh resides (seawater vs. fresh water; Saera-Vila
et al., 2005; Ma et al., 2007; Norbeck et al., 2007; Pierce et al.,
2007; Poppinga et al., 2007; Raine et al., 2007; Di Prinzio et al.,
2010). In light of our current ﬁndings as well previous ﬁndings
by us and others regarding differential binding characteristics
of GHR (Fukada et al., 2004, 2005; Ozaki et al., 2006; Reindl
et al., 2009; Chen et al., 2011), it is reasonable to suggest that
the actions of GH in teleost ﬁsh depend on the abundance of par-
ticular GHR subtypes as well as on the signal pathways that are
expressed in target cells under given developmental/physiological
conditions.
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